These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19817330)

  • 1. Estimating the risk of ovarian cancer.
    Ebell MH
    Am Fam Physician; 2009 Sep; 80(6):632-4. PubMed ID: 19817330
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer of the ovary.
    Cannistra SA
    N Engl J Med; 2004 Dec; 351(24):2519-29. PubMed ID: 15590954
    [No Abstract]   [Full Text] [Related]  

  • 3. Should you be screened for ovarian cancer?
    Johns Hopkins Med Lett Health After 50; 2001 May; 13(3):3. PubMed ID: 14727590
    [No Abstract]   [Full Text] [Related]  

  • 4. Defining women at high risk of ovarian cancer.
    Swisher EM; King MC
    Cancer Res; 2007 Mar; 67(6):2902; author reply 2902-3. PubMed ID: 17363619
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosing ovarian cancer.
    Walker M; Sobel M
    CMAJ; 2018 Oct; 190(42):E1259. PubMed ID: 30348741
    [No Abstract]   [Full Text] [Related]  

  • 6. Hereditary breast and ovarian cancer syndrome.
    ACOG Committee on Practice Bulletins
    Gynecol Oncol; 2009 Apr; 113(1):6-11. PubMed ID: 19309638
    [No Abstract]   [Full Text] [Related]  

  • 7. Socio-demographic and clinical profile of BRCA1/2 mutation carriers opting for prophylactic oophorectomy.
    Dagan E; Gil S; Gershoni-Baruch R
    Prev Med; 2008 May; 46(5):470-2. PubMed ID: 18255133
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of symptom duration in epithelial ovarian cancer on prognostic factors.
    Menczer J; Chetrit A; Sadetzki S;
    Arch Gynecol Obstet; 2009 Jun; 279(6):797-801. PubMed ID: 18936947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers.
    Li AJ; McAllister P; Karlan BY
    Gynecol Oncol; 2010 Jan; 116(1):105-8. PubMed ID: 19818997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
    Forman AD; Hall MJ
    Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian cancer screening and early detection.
    Joyner AB; Runowicz CD
    Womens Health (Lond); 2009 Nov; 5(6):693-9. PubMed ID: 19863472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer: real progress in early detection.
    Johns Hopkins Med Lett Health After 50; 2005 Jan; 16(11):3, 7. PubMed ID: 15693151
    [No Abstract]   [Full Text] [Related]  

  • 13. ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy.
    ACOG
    Obstet Gynecol; 2008 Jan; 111(1):231-41. PubMed ID: 18165419
    [No Abstract]   [Full Text] [Related]  

  • 14. Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective.
    Piek JM; Verheijen RH; van Diest PJ
    Histopathology; 2009 Mar; 54(4):494-5. PubMed ID: 19309405
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ovarian epithelial dysplasia: myth or reality? Review].
    Chêne G; Penault-Llorca F; Le Bouëdec G; Mishellany F; Dauplat MM; Tardieu AS; Pomel C; Jaffeux P; Aublet-Cuvelier B; Pouly JL; Déchelotte P; Dauplat J
    Gynecol Obstet Fertil; 2008; 36(7-8):800-7. PubMed ID: 18657463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. My friend says I should get a CA 125 test to check for ovarian cancer. Should I have this test done?
    Mayo Clin Womens Healthsource; 2007 Sep; 11(9):8. PubMed ID: 17700510
    [No Abstract]   [Full Text] [Related]  

  • 17. Ovarian cancer patient with germline mutations in both BRCA1 and NBN genes.
    Porhanova NV; Sokolenko AP; Sherina NY; Ponomariova DN; Tkachenko NN; Matsko DE; Imyanitov EN
    Cancer Genet Cytogenet; 2008 Oct; 186(2):122-4. PubMed ID: 18940477
    [No Abstract]   [Full Text] [Related]  

  • 18. CA-125 as a biomarker for malignant transformation of endometriosis.
    Check JH
    Fertil Steril; 2009 May; 91(5):e35; author reply e36. PubMed ID: 19338996
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of ovarian cancer development].
    Horiuchi A; Konishi I
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():597-600. PubMed ID: 15535315
    [No Abstract]   [Full Text] [Related]  

  • 20. StatBite: Ovarian cancer: risk of recurrence by stage of diagnosis.
    J Natl Cancer Inst; 2009 Sep; 101(18):1234. PubMed ID: 19738164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.